Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06379126

The Diagnostic and Prognostic Value of TAT, PIC, tPAI·C and TM in Sepsis-induced Coagulopathy

The Diagnostic and Prognostic Value of Thrombin-Antithrombin Complex(TAT), α2-plasmin Inhibitor-plasmin Complex(PIC), Tissue Plasminogen Activator-inhibitor Complex(tPAI·C) and Thrombomodulin(TM) in Sepsis-induced Coagulopathy

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
210 (estimated)
Sponsor
The First Hospital of Jilin University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In order to evaluate the diagnostic and prognostic value of thrombin-antithrombin complex(TAT), α2-plasmin inhibitor-plasmin complex(PIC), tissue plasminogen activator-inhibitor complex(tPAI·C) and thrombomodulin(TM) in sepsis-induced coagulopathy(SIC), hospitalized patients with sepsis were prospectively included. Plasma TAT, PIC, tPAI·C,TM levels within 24 h after sepsis diagnosis were detected by MCL60 chemiluminescence analyzer. According to the SIC score (≥4), they were divided into SIC group and non-SIC group, and ROC curve analysis was performed according to the biomarker test results.

Detailed description

Thrombin-antithrombin complex(TAT), α2-plasmin inhibitor-plasmin complex(PIC), tissue plasminogen activator-inhibitor complex(tPAI·C) and thrombomodulin(TM) can evaluate vascular endothelial damage, thrombin and plasminase activation, and have clinical significance in early diagnosis of DIC, thrombotic disease and monitoring of thrombolysis efficacy. However, whether these biomarkers can be used for early diagnosis of SIC is unclear. In order to evaluate the diagnostic value of TAT, PIC, tPAI·C and TM in sepsis-induced coagulopathy(SIC), hospitalized patients with sepsis were prospectively included. Plasma TAT, PIC, tPAI·C,TM levels within 24 h after sepsis diagnosis were detected by MCL60 chemiluminescence analyzer. According to the SIC score (≥4), they were divided into SIC group and non-SIC group, and receiver operator characteristic(ROC) curve analysis was performed according to the biomarker test results. The area under the curve(AUC) was used to determine whether TAT, PIC, tPAI·C and TM could be used as biomarkers for SIC diagnosis. If AUC is between 0.7 and 0.9, this indicator has diagnostic value.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTTest thrombin-antithrombin complex(TAT), α2-plasmin inhibitor-plasmin complex(PIC), tissue plasminogen activator-inhibitor complex(tPAI·C) and thrombomodulin(TM)Test TAT, PIC, tPAI·C and TM of blood of SIC patients.

Timeline

Start date
2024-04-20
Primary completion
2026-04-20
Completion
2026-04-20
First posted
2024-04-23
Last updated
2024-04-23

Source: ClinicalTrials.gov record NCT06379126. Inclusion in this directory is not an endorsement.